Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RxSight, Inc.RXST · Entity 1226 | Director | June 17, 2026 | June 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RxSight, Inc.
Report date June 17, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 86,227 |
Reported balance
After 2026-06-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-17 · Grant · Acquired 37,037 · Balance 86,227 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026. |
| Common StockSEC Table I · non-derivative | IndirectBy spouse | 3,210 |
Reported balance
Holding disclosure · report date 2026-06-17 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,210 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 474,141 |
Reported balance
Holding disclosure · report date 2026-06-17 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 474,141 F3: Shares held by Andy Corley Living Trust dated 7/17/2013, for which the Reporting Person serves as trustee. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 7,083 |
Reported balance
Holding disclosure · report date 2026-06-17 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 7,083 F4: Shares held by The Corley Foundation (the "Foundation"). The Foundation is a California nonprofit public benefit corporation. The Reporting Person may be deemed to share voting and investment power over the securities held by the Foundation. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 18,708 |
Reported balance
Holding disclosure · report date 2026-06-17 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 18,708 F5: Shares held by the Juana McKay Living Trust, for which the Reporting Person's spouse serves as trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
F2: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.
F3: Shares held by Andy Corley Living Trust dated 7/17/2013, for which the Reporting Person serves as trustee.
F4: Shares held by The Corley Foundation (the "Foundation"). The Foundation is a California nonprofit public benefit corporation. The Reporting Person may be deemed to share voting and investment power over the securities held by the Foundation. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.
F5: Shares held by the Juana McKay Living Trust, for which the Reporting Person's spouse serves as trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2026 Filed Jun 18, 2026 20:08 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 37,037 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-275837 · ownership.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,227 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 01:32 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 10,752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-081953 · ownership.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,190 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 3, 2025. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| January 16, 2025 Filed Jan 18, 2025 00:08 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 1,767 | $31.13 | $55,004.24 |
DisclosureSEC source: 0000950170-25-006858 · ownership.xml · nonDerivative · entry 2 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 3,210 Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 00:08 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 1,443 | $31.19 | $44,999.96 |
DisclosureSEC source: 0000950170-25-006858 · ownership.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 1,443 Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 00:14 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 1,705 | $44.50 | $75,872.50 |
DisclosureSEC source: 0000950170-24-127339 · ownership.xml · nonDerivative · entry 4 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,438 Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 00:14 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 4,090 | $44.98 | $183,968.20 |
DisclosureSEC source: 0000950170-24-127339 · ownership.xml · nonDerivative · entry 3 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,733 Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 00:14 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 5,570 | $45.00 | $250,650.00 |
DisclosureSEC source: 0000950170-24-127339 · ownership.xml · nonDerivative · entry 2 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 474,141 F2 · ownership.nature: Shares held by Andy Corley Living Trust dated 7/17/2013, for which the Reporting Person serves as trustee. Read SEC document |
| November 12, 2024 Filed Nov 15, 2024 00:14 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 11,111 | $45.37 | $504,079.40 |
DisclosureSEC source: 0000950170-24-127339 · ownership.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 468,571 F1 · price: Represents the weighted average share price of an aggregate total of 11,111 shares purchased in the price range of $45.00 to $45.49 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. F2 · ownership.nature: Shares held by Andy Corley Living Trust dated 7/17/2013, for which the Reporting Person serves as trustee. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:11 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 2,554 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-071294 · ownership.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,643 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 6, 2024. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| February 05, 2024 Filed Feb 8, 2024 01:20 UTC | RxSight, Inc. RXST · Entity 1226 | GiftCommon Stock | 7,083 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012451 · ownership.xml · nonDerivative · entry 4 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 18,708 F2 · ownership.nature: Shares held by the Juana McKay Living Trust, for which the Reporting Person's spouse serves as trustee. Read SEC document |
| February 05, 2024 Filed Feb 8, 2024 01:20 UTC | RxSight, Inc. RXST · Entity 1226 | GiftCommon Stock | 7,083 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012451 · ownership.xml · nonDerivative · entry 3 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 0 Read SEC document |
| February 05, 2024 Filed Feb 8, 2024 01:20 UTC | RxSight, Inc. RXST · Entity 1226 | GiftCommon Stock | 46,884 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012451 · ownership.xml · nonDerivative · entry 2 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 457,460 F1 · ownership.nature: Shares held by Andy Corley Living Trust dated 7/17/2013, for which the Reporting Person serves as trustee. Read SEC document |
| February 05, 2024 Filed Feb 8, 2024 01:20 UTC | RxSight, Inc. RXST · Entity 1226 | GiftCommon Stock | 46,884 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012451 · ownership.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,089 Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 21:02 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 2,000 | $45.03 | $90,058.60 |
DisclosureSEC source: 0000950170-24-003324 · ownership.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 11,625 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 14, 2023 by the Reporting Person and the Reporting Person's spouse. F2 · price: Represents the weighted average share price of an aggregate total of 2,000 shares sold in the price range of $45.00 to $45.09 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by the Juana McKay Living Trust, for which the Reporting Person's spouse serves as trustee. Read SEC document |
| December 14, 2023 Filed Dec 19, 2023 00:08 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 2,000 | $40.12 | $80,245.20 |
DisclosureSEC source: 0001209191-23-059040 · doc4.xml · nonDerivative · entry 2 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By spouse's trust Disclosed balance after: 13,625 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 14, 2023 by the Reporting Person and the Reporting Person's spouse. F4 · price: Represents the weighted average share price of an aggregate total of 2,000 shares sold in the price range of $40.00 to $40.4554 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F5 · balance_after: Shares reported as indirectly held by the Andy Corley Living Trust dated 7/17/2013 in previous Form 4 filings. F6 · ownership.nature: Shares held by the Juana McKay Living Trust, for which the Reporting Person's spouse serves as trustee. Read SEC document |
| December 14, 2023 Filed Dec 19, 2023 00:08 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 10,000 | $40.12 | $401,224.00 |
DisclosureSEC source: 0001209191-23-059040 · doc4.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 410,576 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 14, 2023 by the Reporting Person and the Reporting Person's spouse. F2 · price: Represents the weighted average share price of an aggregate total of 10,000 shares sold in the price range of $40.00 to $40.4554 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Andy Corley Living Trust dated 7/17/2013, for which the Reporting Person serves as trustee. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 23:12 UTC | RxSight, Inc. RXST · Entity 1226 | OtherCommon Stock | 7,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055420 · doc4.xml · nonDerivative · entry 4 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 7,083 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of Yelroc Investment Partners RxSight, LLC ("Yelroc") on a pro rata basis based upon each such member's respective capital interests in Yelroc. F3 · ownership.nature: Shares held by The Corley Foundation (the "Foundation"). The Foundation is a California nonprofit public benefit corporation. The Reporting Person may be deemed to share voting and investment power over the securities held by the Foundation. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 23:12 UTC | RxSight, Inc. RXST · Entity 1226 | OtherCommon Stock | 7,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055420 · doc4.xml · nonDerivative · entry 3 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 7,083 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of Yelroc Investment Partners RxSight, LLC ("Yelroc") on a pro rata basis based upon each such member's respective capital interests in Yelroc. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 23:12 UTC | RxSight, Inc. RXST · Entity 1226 | OtherCommon Stock | 45,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055420 · doc4.xml · nonDerivative · entry 2 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,973 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of Yelroc Investment Partners RxSight, LLC ("Yelroc") on a pro rata basis based upon each such member's respective capital interests in Yelroc. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 23:12 UTC | RxSight, Inc. RXST · Entity 1226 | OtherCommon Stock | 81,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-055420 · doc4.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of Yelroc Investment Partners RxSight, LLC ("Yelroc") on a pro rata basis based upon each such member's respective capital interests in Yelroc. F2 · ownership.nature: Shares held by Yelroc. The Reporting Person is sole manager of Yelroc and may be deemed to share voting and investment power over the securities held by Yelroc. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 22:45 UTC | RxSight, Inc. RXST · Entity 1226 | OtherCommon Stock | 81,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-046644 · doc4.xml · nonDerivative · entry 2 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 81,450 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of Flying L Partners, II LLC on a pro rata basis based upon each such member's respective capital interests in Flying L Partners, II LLC. F2 · ownership.nature: Shares held by Yelroc Investment Partners - RxSight. The Reporting Person is a managing member of Yelroc Investment Partners - RxSight and may be deemed to share voting and investment power over the securities held by Yelroc Investment Partners - RxSight. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 22:45 UTC | RxSight, Inc. RXST · Entity 1226 | OtherCommon Stock | 1,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-046644 · doc4.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,293 F1 · shares: Represents a distribution not for value of shares of the Issuer's Common Stock to the members of Flying L Partners, II LLC on a pro rata basis based upon each such member's respective capital interests in Flying L Partners, II LLC. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:29 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 5,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034299 · doc4.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,089 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 1, 2023. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 02, 2022 Filed Jun 4, 2022 00:20 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 10,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034388 · doc4.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,358 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 2, 2022. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| November 17, 2021 Filed Nov 18, 2021 22:02 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 8,150 | $12.49 | $101,752.75 |
DisclosureSEC source: 0000899243-21-045279 · doc4.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,009 Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:34 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 78,125 | $16.00 | $1,250,000.00 |
DisclosureSEC source: 0000899243-21-031823 · doc4.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 436,201 F1 · ownership.nature: Shares held by Andy Corley Living Trust dated 7/17/2013, for which the Reporting Person serves as trustee. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 00:09 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 5,859 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031098 · doc4.xml · nonDerivative · entry 1 Corley Jesse Anderson · CIK 0001874878 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,859 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the date immediately prior to the first annual meeting of stockholders following July 30, 2021. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.